Publications by authors named "Xiao-Yuan Zhong"
Article Synopsis
- This study aimed to compare the effectiveness of different biologic drugs for treating psoriasis over a 52-week period in real-world settings, addressing a lack of existing data.
- A total of 386 patients using biologics like ixekizumab, secukinumab, guselkumab, and adalimumab were analyzed, revealing that guselkumab had the highest drug survival rate at 72.2%.
- Findings indicate that improving drug efficacy is essential for enhancing treatment outcomes in psoriasis patients, as the main reasons for stopping treatment were lack of effectiveness and economic burdens.